Several major manufacturing plants for the asthma and respiratory drug Albuterol have shut down, possibly worsening an already-flaring shortage of the medication that has forced hospitals to devise ...
SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...
For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.
(NewsNation) — A common asthma drug is in short supply after one of the last major manufacturers shut down operations. Akorn Pharmaceuticals, which was one of the major suppliers of albuterol, shut ...
This new data was the result of a recent case-controlled study that aimed to assess the effects of a PDL that provides an exemption from out-of-pocket cost sharing for patients’ asthma medications on ...
A drug used by those with asthma and other lung issues that has been in short supply for several months may now be even more difficult to get. The nation’s main manufacturer of liquid albuterol — a ...
Advisers to the Food and Drug Administration have recommend that drugs Serevent and Foradil no longer be used for asthma. Top-selling Advair was not affected by the recommendation. There is news today ...
Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research shows. Photo by Adobe Stock/HealthDay News Drugs already taken by millions of ...
MILWAUKEE - The FDA says a "rescue drug" may need its own rescue after identifying a shortage of a popular asthma medication, and the closure of an Illinois manufacturing plant may worsen the ...
An advisory committee to the Food and Drug Administration says one type of a long-acting asthma medication has more benefits than risks, but another type has more risks than benefits. The decision may ...
WASHINGTON (Reuters) - U.S. health officials said Thursday they were taking steps to reduce the use of certain asthma drugs because of serious risks, including death. Inhaled medicines known as ...
Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic treatments for asthma. By analyzing clinical parameters and identifying which ...